603259.SH
XD药明康
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 155.84
−4.31%Next report
Analyst consensus
- Next report date
- Oct 28, 2026
- EPS estimate
- CNY 2.11
- Revenue estimate
- CNY 15.3B
Latest reported
- Last report date
- Aug 3, 2026
- EPS actual
- CNY 2.17
- EPS estimate
- CNY 1.56
- Revenue actual
- CNY 16.4B
- Revenue estimate
- CNY 13.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +39.1%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026